Century Therapeutics vs ARS Pharmaceuticals
Century Therapeutics is the larger business, with $109m of revenue in fiscal 2025 against $84.3m for ARS Pharmaceuticals (1.3 times as much). Century Therapeutics grew faster (1556.8% against -5.5%). Century Therapeutics kept more of each dollar of sales as profit: a net margin of -8.8% against -203.3%.
| Latest fiscal year | Century TherapeuticsIPSC, 2025 | ARS PharmaceuticalsSPRY, 2025 |
|---|---|---|
| Revenue | $109m | $84.3m |
| Revenue growth | 1556.8% | -5.5% |
| Net income | −$9.6m | −$171m |
| Operating margin | -15.8% | — |
| Net margin | -8.8% | -203.3% |
| Return on equity | -6.0% | -92.3% |
| Free cash flow | −$105m | −$171m |
| Cash | $61.9m | $41.3m |
| Total debt | $0 | $96.4m |
| Debt to equity | 0.0% | — |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | 78 | 158 |
| Market value | $274m | $298m |
| Price vs our value range | — | — |
| Moat score | — | — |
| Insider trades, 12 months | 3 buys, 20 sales | 0 buys, 5 sales |